Advisory Alpha’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Advisory Alpha’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-335	Closed	-$40K	–	665
2020 Q3	$40K	Buy	+335	New	+$37.6K	0.01%	232
2020 Q2	–	Sell	-1,321	Closed	-$124K	–	629
2020 Q1	$124K	Hold	1,321	–	–	0.03%	129
2019 Q4	$123K	Buy	1,321 +83	+7%	+$7.18K	0.03%	182
2019 Q3	$92.5K	Buy	+1,238	New	+$103K	0.03%	179
2019 Q2	–	Sell	-1,298	Closed	-$109K	–	655
2019 Q1	$109K	Buy	+1,298	New	+$110K	0.04%	157

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return

Advisory Alpha's XBI Position: Q4 2020 in Review

Advisory Alpha sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2020, closing a stake of 335 shares — an estimated $40K sold.

Advisory Alpha first reported a position in XBI in Q1 2019 and held it in 5 quarters. The position peaked at $124K in Q1 2020. 654 funds tracked by Wall St. Rank hold XBI as of Q4 2020.

Advisory Alpha reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2020 after selling out during the quarter.
Advisory Alpha sold 335 State Street SPDR S&P Biotech ETF shares in Q4 2020, an estimated $40K.
Advisory Alpha first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and held it in 5 quarters.
Advisory Alpha's State Street SPDR S&P Biotech ETF position peaked at $124K in Q1 2020.
654 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2020.

Based on Advisory Alpha's 13F filing for Q4 2020, filed 16 Feb 2021.